A comparison of two imaging modalities for detecting lymphatic nodal spread in radiochemotherapy of locally advanced cervical cancer

Background and purpose: In uterine cervical cancer tumour spread reaching the para-aortic lymph nodes is the most significant independent pre-treatment predictor of progression-free survival. When introducing [18F]fluorodeoxyglucose-positron emission tomography (FDG-PET)/computed tomography (CT) in...

Full description

Bibliographic Details
Main Authors: Ann-Charlotte Waldenström, Karin Bergmark, Annika Michanek, Farida Hashimi, Rauni Rossi Norrlund, Caroline E. Olsson, Peter Gjertsson, Henrik Leonhardt
Format: Article
Language:English
Published: Elsevier 2018-10-01
Series:Physics and Imaging in Radiation Oncology
Online Access:http://www.sciencedirect.com/science/article/pii/S2405631618300617
id doaj-2f8e91d4e43a4509ba11cc8d935a2093
record_format Article
spelling doaj-2f8e91d4e43a4509ba11cc8d935a20932020-11-25T00:41:12ZengElsevierPhysics and Imaging in Radiation Oncology2405-63162018-10-0183337A comparison of two imaging modalities for detecting lymphatic nodal spread in radiochemotherapy of locally advanced cervical cancerAnn-Charlotte Waldenström0Karin Bergmark1Annika Michanek2Farida Hashimi3Rauni Rossi Norrlund4Caroline E. Olsson5Peter Gjertsson6Henrik Leonhardt7Department of Oncology, Institute of Clinical Sciences, Sahlgrenska Academy at University of Gothenburg, Sweden; Corresponding author at: Regional Cancer Center West, Medicinaregatan 18 G, SE 41345 Göteborg, Sweden.Department of Oncology, Sahlgrenska University Hospital, SwedenDepartment of Nuclear Medicine, Sahlgrenska University Hospital, SwedenDepartment of Radiology, Sahlgrenska University Hospital, SwedenDepartment of Radiology, Sahlgrenska University Hospital, SwedenDepartment of Radiation Physics, Institute of Clinical Sciences, Sahlgrenska Academy at University of Gothenburg, Sweden; Regional Cancer Center West, The Western Sweden Healthcare Region, Gothenburg, SwedenDepartment of Nuclear Medicine, Sahlgrenska University Hospital, SwedenDepartment of Radiology, Sahlgrenska University Hospital, SwedenBackground and purpose: In uterine cervical cancer tumour spread reaching the para-aortic lymph nodes is the most significant independent pre-treatment predictor of progression-free survival. When introducing [18F]fluorodeoxyglucose-positron emission tomography (FDG-PET)/computed tomography (CT) in our clinic for patients with advanced cervical cancer planned for definitive radiochemotherapy, the purpose of this study was to quantify to what extent the added information lead to changes in radiotherapy planning. Material and methods: We included 25 consecutive patients with cervical cancer stages IB2 – IIIB planned for definitive radiochemotherapy between November 2010 and May 2012. The patients were examined both with magnetic resonance imaging (MRI) and FDG-PET/CT before treatment and after four weeks of treatment. Results: In 11/24 (46%) of the patients the FDG-PET/CT before treatment provided additional diagnostic information leading to changes in treatment planning compared to information from MRI. Seven of these eleven patients (64%) were alive and without evidence of disease at four-year follow-up. The MRI detected pelvic tumour spread not seen on the FDG-PET/CT in 2/24 patients. The disease-free four-year survival was 59%. Conclusions: Additional diagnostic information from FDG-PET/CT changed treatment strategy in almost half of the patients and may have increased chances of survival in this limited group of patients with locally advanced uterine cervical cancer. We recommend both modalities for nodal detection. Keywords: Cervical cancer, Nodal spread, Radiochemotherapy, FDG-PET/CT, MRIhttp://www.sciencedirect.com/science/article/pii/S2405631618300617
collection DOAJ
language English
format Article
sources DOAJ
author Ann-Charlotte Waldenström
Karin Bergmark
Annika Michanek
Farida Hashimi
Rauni Rossi Norrlund
Caroline E. Olsson
Peter Gjertsson
Henrik Leonhardt
spellingShingle Ann-Charlotte Waldenström
Karin Bergmark
Annika Michanek
Farida Hashimi
Rauni Rossi Norrlund
Caroline E. Olsson
Peter Gjertsson
Henrik Leonhardt
A comparison of two imaging modalities for detecting lymphatic nodal spread in radiochemotherapy of locally advanced cervical cancer
Physics and Imaging in Radiation Oncology
author_facet Ann-Charlotte Waldenström
Karin Bergmark
Annika Michanek
Farida Hashimi
Rauni Rossi Norrlund
Caroline E. Olsson
Peter Gjertsson
Henrik Leonhardt
author_sort Ann-Charlotte Waldenström
title A comparison of two imaging modalities for detecting lymphatic nodal spread in radiochemotherapy of locally advanced cervical cancer
title_short A comparison of two imaging modalities for detecting lymphatic nodal spread in radiochemotherapy of locally advanced cervical cancer
title_full A comparison of two imaging modalities for detecting lymphatic nodal spread in radiochemotherapy of locally advanced cervical cancer
title_fullStr A comparison of two imaging modalities for detecting lymphatic nodal spread in radiochemotherapy of locally advanced cervical cancer
title_full_unstemmed A comparison of two imaging modalities for detecting lymphatic nodal spread in radiochemotherapy of locally advanced cervical cancer
title_sort comparison of two imaging modalities for detecting lymphatic nodal spread in radiochemotherapy of locally advanced cervical cancer
publisher Elsevier
series Physics and Imaging in Radiation Oncology
issn 2405-6316
publishDate 2018-10-01
description Background and purpose: In uterine cervical cancer tumour spread reaching the para-aortic lymph nodes is the most significant independent pre-treatment predictor of progression-free survival. When introducing [18F]fluorodeoxyglucose-positron emission tomography (FDG-PET)/computed tomography (CT) in our clinic for patients with advanced cervical cancer planned for definitive radiochemotherapy, the purpose of this study was to quantify to what extent the added information lead to changes in radiotherapy planning. Material and methods: We included 25 consecutive patients with cervical cancer stages IB2 – IIIB planned for definitive radiochemotherapy between November 2010 and May 2012. The patients were examined both with magnetic resonance imaging (MRI) and FDG-PET/CT before treatment and after four weeks of treatment. Results: In 11/24 (46%) of the patients the FDG-PET/CT before treatment provided additional diagnostic information leading to changes in treatment planning compared to information from MRI. Seven of these eleven patients (64%) were alive and without evidence of disease at four-year follow-up. The MRI detected pelvic tumour spread not seen on the FDG-PET/CT in 2/24 patients. The disease-free four-year survival was 59%. Conclusions: Additional diagnostic information from FDG-PET/CT changed treatment strategy in almost half of the patients and may have increased chances of survival in this limited group of patients with locally advanced uterine cervical cancer. We recommend both modalities for nodal detection. Keywords: Cervical cancer, Nodal spread, Radiochemotherapy, FDG-PET/CT, MRI
url http://www.sciencedirect.com/science/article/pii/S2405631618300617
work_keys_str_mv AT anncharlottewaldenstrom acomparisonoftwoimagingmodalitiesfordetectinglymphaticnodalspreadinradiochemotherapyoflocallyadvancedcervicalcancer
AT karinbergmark acomparisonoftwoimagingmodalitiesfordetectinglymphaticnodalspreadinradiochemotherapyoflocallyadvancedcervicalcancer
AT annikamichanek acomparisonoftwoimagingmodalitiesfordetectinglymphaticnodalspreadinradiochemotherapyoflocallyadvancedcervicalcancer
AT faridahashimi acomparisonoftwoimagingmodalitiesfordetectinglymphaticnodalspreadinradiochemotherapyoflocallyadvancedcervicalcancer
AT raunirossinorrlund acomparisonoftwoimagingmodalitiesfordetectinglymphaticnodalspreadinradiochemotherapyoflocallyadvancedcervicalcancer
AT carolineeolsson acomparisonoftwoimagingmodalitiesfordetectinglymphaticnodalspreadinradiochemotherapyoflocallyadvancedcervicalcancer
AT petergjertsson acomparisonoftwoimagingmodalitiesfordetectinglymphaticnodalspreadinradiochemotherapyoflocallyadvancedcervicalcancer
AT henrikleonhardt acomparisonoftwoimagingmodalitiesfordetectinglymphaticnodalspreadinradiochemotherapyoflocallyadvancedcervicalcancer
AT anncharlottewaldenstrom comparisonoftwoimagingmodalitiesfordetectinglymphaticnodalspreadinradiochemotherapyoflocallyadvancedcervicalcancer
AT karinbergmark comparisonoftwoimagingmodalitiesfordetectinglymphaticnodalspreadinradiochemotherapyoflocallyadvancedcervicalcancer
AT annikamichanek comparisonoftwoimagingmodalitiesfordetectinglymphaticnodalspreadinradiochemotherapyoflocallyadvancedcervicalcancer
AT faridahashimi comparisonoftwoimagingmodalitiesfordetectinglymphaticnodalspreadinradiochemotherapyoflocallyadvancedcervicalcancer
AT raunirossinorrlund comparisonoftwoimagingmodalitiesfordetectinglymphaticnodalspreadinradiochemotherapyoflocallyadvancedcervicalcancer
AT carolineeolsson comparisonoftwoimagingmodalitiesfordetectinglymphaticnodalspreadinradiochemotherapyoflocallyadvancedcervicalcancer
AT petergjertsson comparisonoftwoimagingmodalitiesfordetectinglymphaticnodalspreadinradiochemotherapyoflocallyadvancedcervicalcancer
AT henrikleonhardt comparisonoftwoimagingmodalitiesfordetectinglymphaticnodalspreadinradiochemotherapyoflocallyadvancedcervicalcancer
_version_ 1725286750156226560